Replies to post #12715 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>Do you think that Ovation will end up starting the phase III trial prior to FDA approval of rATIII for HD ATIII deficiency?<

Ovation will not move on the CABG/HR indication until the FDA approves ATryn in HD. (I asked this question and Tom Newberry answered it.)